Lord, Abbett & Co
RPTP

Lord, Abbett & Co’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Lord, Abbett & Co’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-384,677
Closed -$4.44M – 1095
2014
Q2 		$4.44M Buy
+384,677
New +$3.5M 0.01% 823
2014
Q1 		– Sell
-543,775
Closed -$7.08M – 1160
2013
Q4 		$7.08M Sell
543,775
-178,074
-25% -$2.45M 0.02% 747
2013
Q3 		$10.8M Buy
721,849
+355,964
+97% +$4.26M 0.02% 624
2013
Q2 		$3.42M Buy
+365,885
New +$2.48M 0.01% 872

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Lord, Abbett & Co's RPTP Position: Q3 2014 in Review

Lord, Abbett & Co sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2014, closing a stake of 384,677 shares — an estimated $4.44M sold.

Lord, Abbett & Co first reported a position in RPTP in Q2 2013 and held it in 4 quarters. The position peaked at $10.8M in Q3 2013. 82 funds tracked by Wall St. Rank hold RPTP as of Q3 2014.

  • Lord, Abbett & Co reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Lord, Abbett & Co sold 384,677 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2014, an estimated $4.44M.
  • Lord, Abbett & Co first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Lord, Abbett & Co's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $10.8M in Q3 2013.
  • 82 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2014.

Based on Lord, Abbett & Co's 13F filing for Q3 2014, filed 14 Nov 2014.